The DOI matches its Crossref record; 39 of the 44 references it cites were found in a registry or an index.
The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
Open accessAbstract
Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) require exposure to IL-23 to become encephalitogenic, but the mechanism by which IL-23 promotes their pathogenicity is not known. Here we found that IL-23 induced production of the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) in T(H)17 cells and that GM-CSF had an essential role in their encephalitogenicity. Our findings identify a chief mechanism that underlies the important role of IL-23 in autoimmune diseases. IL-23 induced a positive feedback loop whereby GM-CSF secreted by T(H)17 cells stimulated the production of IL-23 by antigen-presenting cells. Such cross-regulation of IL-23 and GM-CSF explains the similar pattern of resistance to autoimmunity when either of the two cytokines is absent and identifies T(H)17 cells as a crucial source of GM-CSF in autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and to promote the production of effector molecules (El-Behi et al., 2011).”
From Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression (2018) · cites this paper as El-Behi et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“The initial development of T H 17 cells from naive CD4 + T cells is directed by transforming growth factor-β (TGF-β) in combination with IL-6, IL-21 or IL-9 (refs”
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“The CCR6-CCL20 axis is essential for the entry of T H 17 cells into the CNS in the early phase of EA”
Flagged first, then by citations
5 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- McGeachy, M.J. et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10, 314–324 (2009). · DOI · Paper page
- Park, L.S., Friend, D., Gillis, S. & Urdal, D.L. Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 261, 4177–4183 (1986). · DOI
- Fleetwood, A.J., Lawrence, T., Hamilton, J.A. & Cook, A.D. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178, 5245–5252 (2007). · DOI · Paper page
- Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011). · DOI · Paper page
- Yang, X.O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 28, 29–39 (2008). · DOI · Paper page
- Yamazaki, T. et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181, 8391–8401 (2008). · DOI
Cited by
Sorted by citations
Items 501–600 of 955
Lee, P., Puppi, M., Schluns, K. S., Yu‐Lee, L., Dong, C., & Lacorazza, H. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301372 · Cited by 35
“Hence, loss of ELF4 worsened clinical symptoms of EAE at least in part by increasing infiltration of Th17 cells to the brain.”
BackgroundInfluentialNúñez, S., Sáez, J. J., Fernández, D., Flores‐Santibáñez, F., Alvarez, K. L. F., Tejón, G., Ruiz, P., Villavicencio, P. M., Hidalgo, Y., Manrı́quez, V., et al. (2012) · Immunology · doi:10.1111/imm.12055 · Cited by 41
IL-17 in atherosclerosis: the good and the bad.
Taleb, S., & Tedgui, A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx225 · Cited by 33
“Th17 cells can produce factors such as interleukin (IL)-6, interferon (IFN)-c, and granulocyte-macrophage colony-stimulating factor (GMCSF), which contribute to their pathogenicity.(5,6) Pathogenic Th17 cells can also result from the conversion of other cell types, such as T regulatory (Treg) cells, which lose the exp…”
BackgroundSchneider, C., Shen, C., Gopal, A. A., Douglas, T., Forestell, B., Kauffman, K. D., Rogers, D., Artusa, P., Zhang, Q., Jing, H., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0795-1 · Cited by 31
Sleep loss potentiates Th17‐cell pathogenicity and promotes autoimmune uveitis
Liu, X., Su, Y., Huang, Z., Lv, J., Gu, C., Li, Z., Tao, T., Liu, Y., Jiang, Q., Duan, R., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1250 · Cited by 38
Monteiro, A., & Bonomo, A. (2020) · Bone · doi:10.1016/j.bone.2020.115755 · Cited by 32
Crotti, C., Biggioggero, M., Becciolini, A., Agape, E., & Favalli, E. G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1631795 · Cited by 35
Thomé, R., de Carvalho, A. C., da Costa, T. A., Ishikawa, L. L. W., Fraga‐Silva, T. F. D. C., Sartori, A., de Oliveira, A. L. R., & Verinaud, L. M. C. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12561 · Cited by 34
Purinergic Signaling as a Regulator of Th17 Cell Plasticity
Fernández, D., Flores‐Santibáñez, F., Neira, J., Osorio‐Barrios, F., Tejón, G., Núñez, S., Hidalgo, Y., Fuenzalida, M. J., Meza, D., Ureta, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157889 · Cited by 39
“Other studies revealed that the encephalitogenic properties of Th17 cells depend on GM-CSF production [23,25], whereas IL-10 production has been strongly related to non-pathogenic Th17 cells in EAE [18].”
BackgroundYang, Y., Winger, R. C., Lee, P. W., Nuro-Gyina, P. K., Minc, A., Larson, M., Liu, Y., Pei, W., Rieser, E. L., Racke, M. K., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12441 · Cited by 29
Producing GM-CSF: a unique T helper subset?
Herndler-Brandstetter, D., & Flavell, R. (2014) · Cell Research · doi:10.1038/cr.2014.155 · Cited by 32
Mindur, J. E., Ito, N., Dhib-Jalbut, S., & Ito, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099068 · Cited by 32
“cytokine production is crucial for the encephalitogenic potential of infiltrating T cells and the onset of EAE [24–26], we specifically analyzed the CNS-infiltration of GM-CSF T helper (Th)1 and Th17 cell populations.”
BackgroundSales, M. C., Kasahara, T. M., Sacramento, P. M., Rossi, Á. D., Cafasso, M. O. S. D., Oyamada, H. A. A., Hygino, J., Alvim, F., de Andrade, R. M., Vasconcelos, C. C. F., et al. (2020) · Immunology · doi:10.1111/imm.13281 · Cited by 41
Qu, X., Han, J., Zhang, Y., Wang, X.-Q., Fan, H., Hua, F., & Yao, R.-Q. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1579-0 · Cited by 31
Ferreira, T. B., Hygino, J., Barros, P. O., Teixeira, B., Kasahara, T. M., Linhares, U. C., Lopes, L. M., Vasconcelos, C. C. F., Alvarenga, R. M. P., Wing, A. C., et al. (2014) · Immunology · doi:10.1111/imm.12334 · Cited by 30
Comerford, I., Kara, E. E., McKenzie, D. R., & McColl, S. R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12616 · Cited by 33
“Studies imply that the cytokine IL-23 is essential for the maintenance of the pathogenic Th17 population that drives autoimmunity (Stritesky et al, 2008; El-Behi et al, 2011).”
BackgroundDirect and Indirect Regulatory Mechanisms in TH17 cell Differentiation and Functions
Bi, Y., & Yang, R. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02686.x · Cited by 27
Qiu, Y., Xu, Y., Ding, X., Zhao, C., Cheng, H., & Li, G. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003284 · Cited by 29
“On one hand, TH17-derived cytokines, such as IL-17A and GM-CSF, can enhance anti-tumor immunity by activating dendritic cells and recruiting CD8 + T cells [140–142].”
Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis
Liu, X.-X., Gu, C.-Y., Lv, J., Jiang, Q., Ding, W., Huang, Z.-H., Liu, Y., Su, Y., Zhang, C., Xu, Z., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02829-3 · Cited by 30
“In addition, GM-CSF is a marker that distinguishes pathogenic Th17 cells from non-pathogenic Th17 cells [45].”
BackgroundThe Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
Meng, X.-T., Shi, Y.-Y., Zhang, H., & Zhou, H. (2020) · Journal of Ophthalmology · doi:10.1155/2020/6917185 · Cited by 32
“In addition, previous studies found IL-23-+17 cells feedback loop, wherein IL-23 maintained +17 cell population, produced IL-17, and also induced +17 cells to secrete GMCSF, and GM-CSF in turn induced antigen-presenting cells to further secrete IL-23, thereby constantly maintaining the +17 cell chronic reaction [93].”
ResultThe Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis
Monaghan, K. L., & Wan, E. C. K. (2020) · Cells · doi:10.3390/cells9030611 · Cited by 35
“The role of Th17 cells in EAE is further supported by an elegant study that demonstrated that the upregulation of both IL-23 and RORγt license the Th17 cells to produce GM-CSF.”
InfluentialLack of Ikaros Deregulates Inflammatory Gene Programs in T Cells
Ana, C. L. D., Arakcheeva, K., Agnihotri, P., Derosia, N. M., & Winandy, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801270 · Cited by 32
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.
Hosseini, A., Ghaedi, K., Tanhaei, S., Ganjalıkhani-Hakemi, M., Teimuri, S., Etemadifar, M., & Esfahani, M. H. N. (2016) · PubMed Central · doi:10.22074/cellj.2016.4565 · Cited by 25
Mangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., Ditto, N. T., Lin, Z., Yang, X., Cotter, P., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224246 · Cited by 32
Guéry, J., Lélu, K., Laffont, S., & Garnier, L. (2015) · Biomedical Journal · doi:10.4103/2319-4170.158509 · Cited by 35
Kalantari, T., Karimi, M. H., Ciric, B., Yan, Y., Rostami, A. M., & Kamali‐Sarvestani, E. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12266 · Cited by 22
Self-citationBłyszczuk, P., Behnke, S., Lüscher, T. F., Eriksson, U., & Kania, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.008 · Cited by 27
Metabolic regulation and function of T helper cells in neuroinflammation
Spiljar, M., & Kuchroo, V. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00959-z · Cited by 29
Kim, G., Kim, W., Lim, S., Lee, H., Koo, J., Nam, K.-H., Kim, S., Park, S., & Choi, J. (2021) · Advanced Science · doi:10.1002/advs.202004973 · Cited by 33
Chen, J., Martindale, J. L., Abdelmohsen, K., Kumar, G., Fortina, P. M., Gorospe, M., Rostami, A. M., & Yu, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900769 · Cited by 34
Self-citationCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Flores‐Borja, F., Irshad, S., Gordon, P., Wong, F., Sheriff, I., Tutt, A. N. J., & Ng, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/7803091 · Cited by 33
Nacka-Aleksić, M., Djikić, J., Pilipović, I., Stojić-Vukanić, Z., Kosec, D. J., Bufan, B., Arsenović-Ranin, N., Dimitrijević, M., & Leposavić, G. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.017 · Cited by 32
IκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection
Annemann, M., Wang, Z., Plaza-Sirvent, C., Glauben, R., Schuster, M., Sander, F. E., Mamareli, P., Kühl, A., Siegmund, B., Lochner, M., et al. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1401964 · Cited by 29
“Expression of GM-CSF was reported to be responsible for the pathogenicity of Th17 cells during experimental autoimmune encephalomyelitis (EAE) (9, 10), the murine disease model for multiple sclerosis.”
BackgroundInfluentialJun, S.-M., Ochoa-Repáraz, J., Złotkowska, D., Hoyt, T. R., & Pascual, D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.003 · Cited by 29
“Recent findings have shown that IL-23 also stimulates GM-CSF-producing autoreactive CD4+ T cells, which in turn induce Th17 cells, causing an exacerbation of disease because of myeloid cell recruitment to the CNS (Codarri et al., 2011; El-Behi et al., 2011).”
BackgroundThe hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation
Benallegue, N., Kébir, H., Kapoor, R., Crockett, A. M., Li, C., Cheslow, L., Abdel-Hakeem, M. S., Gesualdi, J., Miller, M. C., Wherry, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab083 · Cited by 31
“These T-cell subsets were shown to have a greater immunopathogenic potential in multiple sclerosis and EAE than single cytokine producers.(7,34,35) Notably, this effect was restricted to the CNS, as the production of pro-inflammatory mediators by CD4 T cells in the spleen was unaffected (Fig.”
BackgroundHost Response to Coccidioides Infection: Fungal Immunity
Diep, A. L., & Hoyer, K. K. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.581101 · Cited by 36
“There are two known Th17 subsets: pathogenic (GM-CSF producing) Th17 and non-pathogenic (IL-10 producing) Th17 (El-Behi et al., 2011; Bystrom et al., 2019).”
BackgroundAn emerging role of interleukin-23 in rheumatoid arthritis
Yuan, N., Yu, G., Liu, D., Wang, X., & Zhao, L. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1610429 · Cited by 29
Dimitrijević, M., Arsenović-Ranin, N., Kosec, D. J., Bufan, B., Nacka-Aleksić, M., Pilipović, I., & Leposavić, G. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.311 · Cited by 32
Sen, S., He, Z.-H., Ghosh, S., Dery, K. J., Yang, L.-M., Zhang, J., & Sun, Z.-M. (2018) · Journal of Immunology · doi:10.4049/jimmunol.1701654 · Cited by 28
“For visualization of CNS infiltration by cells of the immune system and demyelination, spinal cords of mice in which EAE was induced were collected on day 15.”
BackgroundInfluentialMontes‐Cobos, E., Schweingruber, N., Li, X., Fischer, H. J., Reichardt, H. M., & Lühder, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01319 · Cited by 32
Regulation of Memory T Cells by Interleukin-23
Li, Y., Wang, H., Lu, H., & Hua, S. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000445834 · Cited by 33
Cheng, H., Xi, Y., Chi, X., Wu, Y., & Liu, G.-Z. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2016.58817 · Cited by 28
“Recently it has been reported that “classical” Th17 cells, which mainly produce IL-17, are not pathogenic, while GM-CSF is critical for the pathogenicity of Th17 cells [5, 6].”
Sarkar, K., Sadhukhan, S., Han, S.-S., & Vyas, Y. (2015) · Blood · doi:10.1182/blood-2015-05-646182 · Cited by 28
Saligrama, N., Case, L., del Río, R., Noubade, R., & Teuscher, C. (2013) · Journal of Immunology · doi:10.4049/jimmunol.1203137 · Cited by 28
Green tea: a new option for the prevention or control of osteoarthritis
Katiyar, S., & Raman, C. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3428 · Cited by 28
Laouarem, Y., Kassoussi, A., Zahaf, A., Hutteau-Hamel, T., Mellouk, A., Bobé, P., Mattern, C., Schumacher, M., & Traiffort, É. (2021) · Glia · doi:10.1002/glia.23967 · Cited by 31
“one of the cytokines that are indispensable for the production of GMCSF and thus pathogenic T cell generation in the EAE model (El-Behi et al., 2011; Komuczki et al., 2019).”
BackgroundResultConstitutive Expression of CCL22 Is Mediated by T Cell–Derived GM-CSF
Piseddu, I., Röhrle, N., Knott, M. M. L., Moder, S., Eiber, S., Schnell, K., Vetter, V. K., Meyer, B., Layritz, P., Kühnemuth, B., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000004 · Cited by 29
GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
Kim, I., Koh, C., Jeon, I., Shin, K., Kang, T.-S., Bae, E., Seo, H., Ko, H., Kim, B., Chung, Y., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0518 · Cited by 31
Sendo, S., Saegusa, J., Okano, T., Takahashi, S., Akashi, K., & Morinobu, A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40231 · Cited by 27
“Some CD4+ T cells produce GM-CSF under inflammatory conditions (31,32).”
BackgroundThe influence of sodium on pathophysiology of multiple sclerosis
Zostawa, J., Adamczyk-Zostawa, J., Sowa, P., & Adamczyk-Sowa, M. H. (2017) · Neurological Sciences · doi:10.1007/s10072-016-2802-8 · Cited by 32
“The Th17 cells induced by high-salt concentration upregulate the production of pro-inflammatory cytokines GM-CSF, TNFa, IL-2, IL-9, several chemokines [131, 132], and CCR6 [133], which are”
BackgroundZhou, H., Wang, Y., Lian, Q., Yang, B., Ma, Y., Wu, X., Sun, S., Liu, Y., & Sun, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201343744 · Cited by 26
Mannie, M. D., Blanchfield, L., Islam, S. M. T., & Abbott, D. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00255 · Cited by 25
“These findings indicate that the high affinity docking of the cytokine domain to cytokine receptors on APC was the key event for potentiated antigen recognition.”
BackgroundIvan, D. C., Walthert, S., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666961 · Cited by 27
“While the GM-CSF-mediated upregulation of the anti-inflammatory gene Arg1 appears somewhat in contrast wi th the d i sease -dr iv ing func t ion of GM-CSF in neuroinflammatory models (67, 68), MoCs stimulated with GM-CSF have been described as cells sharing pro- and antiinflammatory characteristics (50–52), with a rec…”
BackgroundLee, J., Cho, W., Yu, J., & Hyun, Y. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03468-6 · Cited by 26
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
Mu, X., Liu, K., Li, H., Wang, F.-S., & Xu, R.-N. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00719-3 · Cited by 26
“In another experimental autoimmune encephalomyelitis mouse model, it was reported that GM-CSF is critical for the proinflammatory functions of Th17 cells; GM-CSF blockade, but not IL-17 depletion, may efficiently inhibit tissue inflammation [4].”
BackgroundPotential for Targeting Myeloid Cells in Controlling CNS Inflammation
Ifergan, I., & Miller, S. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571897 · Cited by 33
“However, in 2011, the CNS pathogenicity of TH17 cells was reported to be primarily associated with their production of GM-CSF (59, 60).”
BackgroundInfluentialYang, M., Sun, L., Han, J., Zheng, C., Liang, H., Zhu, J., & Jin, T. (2019) · Molecular Brain · doi:10.1186/s13041-019-0532-6 · Cited by 32
Zhang, F., Zhang, Y., Yang, T., Ye, Z.-Q., Tian, J., Fang, H.-R., Han, J., Wang, Z.-Z., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00863 · Cited by 26
Li, R., & Bar‐Or, A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029108 · Cited by 32
“GM-CSF knockoutmice are resistant to active EAE induction (McQualter et al. 2001) and GM-CSF-deficient Th17 cells fail to induce passive EAE (Ponomarev et al. 2007; Codarri et al. 2011; El-Behi et al. 2011).”
BackgroundRegulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt
He, Z., Wang, F., Zhang, J., Sen, S., Pang, Q., Luo, S., Gwack, Y., & Sun, Z. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700457 · Cited by 29
Dendritic cells as therapeutic targets in neuroinflammation
Lüssi, F., Zipp, F., & Witsch, E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2170-9 · Cited by 26
“This approach is currently investigated in phase II clinical trials in patients with rheumatoid arthritis in which two antibodies (MOR103 and KB003) designed to block GM-CSF signalling are being tested, after MOR103 demonstrated preliminary evidence of efficiency in this autoimmune disease [209].”
BackgroundInfluentialYeh, W.-I., McWilliams, I. L., & Harrington, L. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100031 · Cited by 26
“expression of this cytokine by CD4 T cells is essential for the development of EAE (18, 19).”
BackgroundTransgenic Expression of GM-CSF in T Cells Causes Disseminated Histiocytosis
van Nieuwenhuijze, A. E. M., Coghill, E., Gray, D. H. D., Prato, S., Metcalf, D., Alexander, W. S., & Wicks, I. P. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.014 · Cited by 27
Zhang, H., Sun, Y., Fan, M., Zhang, Y., Liang, Z., Zhang, L.-C., Gao, X., He, X., Li, X., Zhao, D.-Q., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7836 · Cited by 25
“IL-1 or TGF-β plus IL-6 stimulate Th17 to produce the IL-17A, IL-10, and GM-CSF, which participate in autoimmune diseases and granulocyte-dependent responses (El-Behi et al., 2011).”
BackgroundZhao, L., Liu, Y., Ma, B., Liu, X., Wei, R., & Nian, H. (2023) · The FASEB Journal · doi:10.1096/fj.202201548r · Cited by 26
Advancements in the Alcohol-Associated Liver Disease Model
Zhu, L., Li, H.-D., Xu, J., Li, J., Cheng, M., Meng, X., Huang, C., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12081035 · Cited by 30
“Furthermore, macrophages activate T helper cells to release IL-17 by producing IL-23, which, in turn, mediates neutrophil production/release through an increase in granulocyte colonystimulating factor [88].”
BackgroundKim, S.-J., Lu, H. C., Steelman, A. J., & Li, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117636119 · Cited by 25
Mitchell, D. K., Shireman, J. M., Potchanant, E. A. S., Lara-Velazquez, M. A., & Dey, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.716947 · Cited by 27
Chang, Y.-N., Kim, J. W., Yang, S., Chung, D., Ko, J., Moon, J., & Kim, H. Y. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1311 · Cited by 25
“Although GM-CSF has a protective effect, it also acts as an essential mediator of tissue inflammation.(35,36) GM-CSF exacerbates colitis by promoting the accumulation of Ly-6C inflammatory monocytes(17,18); namely, NCR ILC3s promote inflammation through GM-CSF-induced accumulation of inflammatory monocytes in the anti…”
BackgroundChu, S., McCormick, T. S., Lazarus, H. M., Leal, L. O., & Ghannoum, M. A. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108731 · Cited by 30
REGγ controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells
Zhou, L., Yao, L., Zhang, Q., Xie, W., Wang, X., Zhang, H., Xu, J., Lin, Q., Li, Q., Yang, X., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0287-0 · Cited by 29
Whitehead, G. S., Kang, H. S., Thomas, S. Y., Medvedev, A. V., Karcz, T. P., Izumi, G., Nakano, K., Makarov, S., Nakano, H., Jetten, A. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125528 · Cited by 24
“As seen in the previous experiments, TNF was also significantly reduced, whereas GM-CSF was not.”
BackgroundInfluentialIn Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease
Delens, L., Ehx, G., Somja, J., Vrancken, L., Belle, L., Seidel, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.10.007 · Cited by 25
STAT-3–independent production of IL-17 by mouse innate-like αβ T cells controls ocular infection
Leger, A. J. S., Hansen, A. M., Karaüzüm, H., Horai, R., Yu, C., Laurence, A. D. J., Mayer-Barber, K. D., Silver, P. B., Villasmil, R., Egwuagu, C. E., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170369 · Cited by 25
“The cytokines IL-23, IL-6, and IL-21 are all known to induce IL-17 production in CD4+ T cells by activation of STAT-3, which is considered to be a critical activating signal for the induction and maintenance of the Th17 lineage (Bettelli et al., 2006; Harris et al., 2007; Huber et al., 2009; Ghoreschi et al., 2010; El…”
BackgroundSeshadri, S., Allan, D., Carlyle, J. R., & Zenewicz, L. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006690 · Cited by 26
“GM-CSF also promotes an inflammatory environment for the adaptive arm of the immune system, especially in Th17 cell biology [64, 65].”
BackgroundMidkine and multiple sclerosis
Takeuchi, H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12499 · Cited by 25
“…et al., 2006; Ivanov et al., 2006; Mangan et al., 2006; Weaver et al., 2006; Codarri BJP British Journal ofPharmacology DOI:10.1111/bph.12499 www.brjpharmacol.org British Journal of Pharmacology (2014) 171 931–935 931© 2013 The British Pharmacological Society et al., 2011; El-Behi et al., 2011).”
BackgroundInfluentialMiller, N. M., Shriver, L. P., Bodiga, V. L., Ray, A., Basu, S., Ahuja, R., Jana, A., Pahan, K., & Dittel, B. N. (2013) · ASN NEURO · doi:10.1042/an20120087 · Cited by 19
“Although the exact mechanisms whereby CD4 T-cells drive CNS autoimmunity are not well understood, both cell types produce GM-CSF (granulocyte/macrophage colony-stimulating factor), a key cytokine required for the initiation of disease (El-Behi et al. 2011; McQualter et al., 2001; Ponomarev et al., 2007).”
BackgroundSelf-citationTh17 Cells Induce a Distinct Graft Rejection Response That Does Not Require IL-17A
Agorogiannis, E. I., Regateiro, F. S., Howie, D., Waldmann, H., & Cobbold, S. P. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03971.x · Cited by 23
“It is also possible that neither IL-17A nor IL-17F are essential to the rejection process mediated by Th17 cells (59), with granulocytemacrophage colony stimulating factor (CSF2) (60,61) and IL-22 (62) as other candidates to be excluded.”
BackgroundKusuda, M., Haroon, N., & Nakamura, A. (2021) · Modern Rheumatology · doi:10.1093/mr/roab057 · Cited by 26
Yu, W. H., Ying, J., Wang, X., Liu, X., Zhao, T., Yoon, S., Zheng, Q., Fang, Y., Yang, D., & Hua, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691230 · Cited by 29
“With the increasing life expectancy and aging of the global population, the number of patients with neurodegenerative diseases is continuously increasing (Feigin et al., 2017; GBD 2015 Neurological Disorders Collaborator Group, 2017).”
BackgroundWu, S., Ma, R., Zhong, Y., Chen, Z., Zhou, H., Zhou, M., Chong, W. P., & Chen, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147517 · Cited by 24
“For example, although Th1 cells and their signature cytokine IFN-γ are demonstrated to be pathogenic in EAU [13], innate IFN-γ from natural killer (NK) cells and natural killer T (NKT) cells are protective, as systemic depletion of IFN-γ exacerbates the disease development, in association with elevated Th17 response,…”
BackgroundInfluentialIL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production
Yoshimura, S., Thomé, R., Konno, S., Mari, E. R., Rasouli, J., Hwang, D., Boehm, A., Lǐ, Y., Zhang, G., Ćirić, B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801113 · Cited by 25
“inflammation by activating CNS-infiltrating myeloid cells, such as monocytes and dendritic cells (DCs), and perpetuating inflammation (4, 5).”
BackgroundSelf-citationGarnier, L., Laffont, S., Lélu, K., Yogev, N., Waisman, A., & Guéry, J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800417 · Cited by 24
“genic Th17 cells is essential for the induction of neuroinflammation in EAE (34, 35).”
BackgroundJayaraman, A. K., Soni, A., Prabhakar, B. S., Holterman, M., & Jayaraman, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.015 · Cited by 26
“[50-52] or Th17 cells alone [45-46, 49-51], could mediate EAE.”
BackgroundAlphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage
Griffin, D. E. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0434-6 · Cited by 25
“cells and recruits myeloid cells into the CNS, but themechanism by which this leads to disease has not been identified [47, 50, 51].”
BackgroundThe balance of intestinal Foxp3 + regulatory T cells and Th17 cells and its biological significance
Shen, X., Du, J., Guan, W., & Zhao, Y. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.882232 · Cited by 25
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice
Zayoud, M., Malki, K., Frauenknecht, K., Trinschek, B., Kloos, L., Karram, K., Wanke, F., Georgescu, J., Hartwig, U., Sommer, C., et al. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9466-4 · Cited by 24
“We speculate that mouse monocytes cannot replace human monocytes in our model due to lack of compatible receptors for human T cell derived cytokines important in EAE such as GM-CSF (Codarri et al. 2011; El-Behi et al. 2011).”
BackgroundAdult Onset Still's Disease and Autoinflammation
Efthimiou, P., Moorthy, L. N., Mavragani, C. P., Skokos, D., & Fautrel, B. (2012) · International Journal of Inflammation · doi:10.1155/2012/964751 · Cited by 24
IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils
Savarin, C., Stohlman, S., Hinton, D., Ransohoff, R., Cua, D., & Bergmann, C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-104 · Cited by 24
“These include excessive CNS neutrophil infiltration and release of degrading enzymes, free radicals and pro-inflammatory cytokines, direct IL-17-mediated neuronal toxicity [25] , and/or secretion of granulocyte macrophage colonystimulating factor (GM-CSF) as the pathogenic effector molecule [26] [27] [28] .”
BackgroundInfluentialO'Connor, R., Li, X., Blumerman, S., Anderton, S., Noelle, R., & Dalton, D. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1101118 · Cited by 24
Guo, R., Kong, J., Tang, P., Wang, S., Sang, L., Liu, L., Guo, R., Yan, K., Qi, M. Y., Bian, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202304539 · Cited by 21
Shao, S., Chen, C., Shi, G.-N., Zhou, Y., Wei, Y.-Z., Wu, L., Sun, L., & Zhang, T.-T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.026 · Cited by 23
Yamada, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086930 · Cited by 29
“In mice, GM-CSF is a critical effector cytokine defining the pathogenicity of Th17 cells [25].”
BackgroundDamiani, G. B., McCormick, T. S., Leal, L. O., & Ghannoum, M. A. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108292 · Cited by 26
Shahid, A., & Bharadwaj, M. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.07.001 · Cited by 24
GM-CSF producing autoreactive CD4+ T cells in type 1 diabetes
Knoop, J., Gavrisan, A., Kuehn, D., Reinhardt, J., Heinrich, M., Hippich, M., Eugster, A., Ockert, C., Ziegler, A., & Bonifacio, E. E. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.12.002 · Cited by 21
Singh, S., Barr, H. L., Liu, Y., Robins, A., Heeb, S., Williams, P. M., Fogarty, A., Cámara, M., & Martínez‐Pomares, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117447 · Cited by 23
“Also, recent publications indicate that GM-CSF production by Th17 cells is responsible for their pathological role during chronic inflammation [47,48].”
BackgroundSimilarities and Differences Between Juvenile and Adult Spondyloarthropathies
Fisher, C., Ciurtin, C., Leandro, M. J., Sen, D., & Wedderburn, L. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.681621 · Cited by 31
“IL23 is less well-studied in ERA.”
BackgroundInfluentialReynoso-Moreno, I., Tietz, S., Vallini, E., Engelhardt, B., Gertsch, J., & Chicca, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00214 · Cited by 28
PD-1 Blockade Reverses Obesity-Mediated T Cell Priming Impairment
Le, C. T., Khuat, L. T., Caryotakis, S. E., Wang, M., Dunai, C., Nguyen, A. V., Vick, L. V., Stoffel, K. M., Blazar, B. R., Monjazeb, A. M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590568 · Cited by 19
Metadata
- Authors
- El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A.
- Affiliations
- Thomas Jefferson University (US)
- Versiti Blood Center of Wisconsin (US)
- Corresponding author
- Rostami, Abdolmohamad
- ORCID
- Venue
- Nature Immunology
- Published
- 2011-04-24
- Volume
- 12
- Issue
- 6
- Pages
- 568-575
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3116521
- OpenAlex
- W2084388036
- Cited by
- 1,071
- References
- 44
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 38 · 2023: 58 · 2022: 62 · 2021: 72 · 2020: 82 · 2019: 71 · 2018: 74 · 2017: 96 · 2016: 82 · 2015: 108 · 2014: 91 · 2013: 80 · 2012: 73
- FWCI
- 37.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Multiple Sclerosis Society
- Mary E. Groff Surgical and Medical Research and Education Charitable Trust
- National Institute of Neurological Disorders and Stroke (R01NS046782)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- Th17 cells, experimental autoimmune encephalomyelitis, IL-23, GM-CSF, interleukin-1, encephalitogenicity, autoimmune disease, antigen-presenting cells, positive feedback loop, T helper cells
- MeSH terms
- Animals, Antibodies, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Glycoproteins, Interleukin-1, Mice, Inbred C57BL, Mice, Transgenic, Peptide Fragments, CD4-Positive T-Lymphocytes, Granulocyte-Macrophage Colony-Stimulating Factor, Transforming Growth Factor beta, Mice, Knockout, Th1 Cells, Coculture Techniques, CD11c Antigen, Mice, Interleukin-1beta, Interleukin-23, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review